Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
The American Journal of Gastroenterology|September 28, 2004
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's diseaseWilliam J Sandborn, Stephen Hanauer, Edward V Loftus, et al.
Clinical and Translational Gastroenterology|May 28, 2025
Effects of Ricinoleic Acid (Castor Oil) on Gut Permeability in Healthy Participants: Provocative Test for Treatments Aimed at Restoring Barrier FunctionDavid Yi Yang, Camille Lupianez-Merly, Kara J Jencks, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 7, 2022
Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal StudyThomas F Imperiale, Philip T Lavin, Tara N Marti, et al.
Mayo Clinic Proceedings|May 6, 2017
Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer ScreeningLila J Finney Rutten, Robert M Jacobson, Patrick M Wilson, et al.
Gastroenterology|January 13, 2010
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitisWilliam J Sandborn, Joshua Korzenik, Bret Lashner, et al.
Crohn'S & Colitis 360|February 13, 2023
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic ColitisThomas W Fredrick, Guilherme P Ramos, Manuel B Braga Neto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2026
Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1b Esophageal Adenocarcinoma: A Patient-Level Pooled Analysis of International StudiesAmrit K Kamboj, Saam Dilmaghani, Rohit Goyal, et al.
Gastroenterology|August 30, 2008
A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adultsApril B M Grudell, Seth Sweetser, Michael Camilleri, et al.
Inflammatory Bowel Diseases|November 9, 2020
The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter StudyGuilherme Piovezani Ramos, Christina Dimopoulos, Nicholas M McDonald, et al.
Inflammatory Bowel Diseases|August 28, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Pageof 16